Simon trained as a biologist, receiving a BSc and PhD from the University of Southampton and has worked in the radiation protection field for over 25 years. In his role of Head of Radiation Effects Department he has responsibility for epidemiological and experimental research related to radiation risk; this includes both ionising and non-ionising radiations and ultra-violet light. He has wide ranging research interests on the mechanisms of radiogenic diseases.
Ken's area of research began in the field of tumour viruses (Hepatitis B Virus, Papillomavirus and Adeno-associated virus) and gradually extended to tumorigenesis, DNA damage, Radiobiology, Cardiovascular Disease, and Ageing.
Liz is a Ph. D. physics graduate with 10 years of experience as a Radiation Protection Scientist at PHE's Centre for Radiation, Chemical and Environmental Effects. As head of the Cytogenetics Group and the Chromosome Dosimetry Service, Liz's main field of research is radiation biodosimetry - using the cytogenetic (cellular and chromosomal) effects of ionising radiation to estimate individual doses.
After obtaining a Master's degree in cellular and integrative neuroscience at University of Strasbourg (France) and a PhD in medicine in the field of neurophysiology of pain at University of Helsinki (Finland), Nora moved to the UK as a post-doc in neurobehavioural genetics at the MRC Harwell (UK) and then joined PHE to lead the Neurobiology group.
Christophe identified the first radiotherapy patient whose radiation toxicity was due to a defect in DNA DSB repair which was thought to be almost incompatible with survival at the time; it was found later that the patient had a mutation in ligase IV. After several post-doctorate positions, Christophe became in 2005 the head of the Cancer Mechanisms and Biomarkers group in the Radiation Effects department.